Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reproductive Biology and Endocrinology
Published in: Reproductive Biology and Endocrinology 1/2006

Open Access 01-12-2006 | Research

Comparison of RCAS1 and metallothionein expression and the presence and activity of immune cells in human ovarian and abdominal wall endometriomas

Authors: Lukasz Wicherek, Magdalena Dutsch-Wicherek, Krystyna Galazka, Tomasz Banas, Tadeusz Popiela, Agata Lazar, Beata Kleinrok-Podsiadlo

Published in: Reproductive Biology and Endocrinology | Issue 1/2006

Login to get access

Abstract

Background

The coexistence of endometrial and immune cells during decidualization is preserved by the ability of endometrial cells to regulate the cytotoxic immune activity and their capability to be resistant to immune-mediated apoptosis. These phenomena enable the survival of endometrial ectopic cells. RCAS1 is responsible for regulation of cytotoxic activity. Metallothionein expression seems to protect endometrial cells against apoptosis. The aim of the present study was to evaluate RCAS1 and metallothionein expression in human ovarian and scar endometriomas in relation to the presence of immune cells and their activity.

Methods

Metallothionein, RCAS1, CD25, CD69, CD56, CD16, CD68 antigen expression was assessed by immunohistochemistry in ovarian and scar endometriomas tissue samples which were obtained from 33 patients. The secretory endometrium was used as a control group (15 patients).

Results

The lowest metallothionein expression was revealed in ovarian endometriomas in comparison to scar endometriomas and to the control group. RCAS1 expression was at the highest level in the secretory endometrium and it was at comparable levels in ovarian and scar endometriomas. Similarly, the number of CD56-positive cells was lower in scar and ovarian endometriomas than in the secretory endometrium. The highest number of macrophages was found in ovarian endometriomas. RCAS1-positive macrophages were observed only in ovarian endometriomas. CD25 and CD69 antigen expression was higher in scar and ovarian endometriomas than in the control group.

Conclusion

The expression of RCAS1 and metallothionein by endometrial cells may favor the persistence of these cells in ectopic localization both in scar following cesarean section and in ovarian endometriosis.
Appendix
Available only for authorised users
Literature
1.
Douglas C, Rotimi O: Extragenital endometriosis – a clinicopathological review of a Glasgow hospital experience with case illustrations. J Obstet Gynaecol. 2004, 24: 804-808. 10.1080/01443610400009568.CrossRefPubMed
2.
Scott RB, Telinde RW: Clinical external endometriosis: probable viability of menstrually shed fragments of endometrium. Obstet Gynecol. 1954, 4: 502-510.PubMed
3.
Sampson JA: Endometrial carcinoma of the ovary, arising in endometrial tissue of that organ. Arch Surg. 1925, 10: 1-72.CrossRef
4.
Fazleabas AT: A baboon model for inducing endometriosis. Methods Mol Med. 2006, 121: 95-99.PubMed
5.
Nishida M, Nasu K, Fukuda J, Kawano Y, Narahara H, Miyakawa I: Down-regulation of Interleukin-1 receptor type 1 expression causes the dysregulated expression of CXC chemokines in endometriotic stromal cells: a possible mechanism for altered immunological functions in endometriosis. J Clin Endocrinol Metab. 2004, 89: 5094-5100. 10.1210/jc.2004-0354.CrossRefPubMed
6.
Beliard A, Noel A, Foidart JM: Reduction of apoptosis and proliferation in endometriosis. Fertil Steril. 2004, 82: 80-85. 10.1016/j.fertnstert.2003.11.048.CrossRefPubMed
7.
Nakashima M, Sonoda K, Watanabe T: Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med. 1999, 5: 938-942. 10.1038/11383.CrossRefPubMed
8.
Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T: Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer. Gynecol Oncol. 2005, 97: 772-779. 10.1016/j.ygyno.2005.02.025.CrossRefPubMed
9.
Chiou SH, Sheu BC, Chang WC, Huang SC, Hong-Nerng H: Current concepts of tumor-infiltrating lymphocytes in human malignancies. J Reprod Immunol. 2005, 67: 35-50. 10.1016/j.jri.2005.06.002.CrossRefPubMed
10.
Wicherek L, Popiela TJ, Galazka K, Dutsch-Wicherek M, Oplawski M, Basta A, Klimek M: Metallothionein and RCAS1 expression in comparison to immunological cells activity in endometriosis, endometrial adenocarcinoma and endometrium according to menstrual cycle changes. Gynecol Oncol. 2005, 99: 622-630. 10.1016/j.ygyno.2005.07.003.CrossRefPubMed
11.
Matsushima T, Nakashima M, Oshima K, Abe Y, Nishimura J, Nawata H, Watanabe T, Muta K: Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells. Blood. 2001, 98: 313-321. 10.1182/blood.V98.2.313.CrossRefPubMed
12.
Dutsch-Wicherek M, Tomaszewska R, Popiela TJ, Wicherek L, Szywala M, Wierzchowski W, Modrzejewski M, Klimek M, Czekierdowska S, Skladzien J: RCAS1 expression in lymphoid tissue of Waldeyer's ring. Pol J Environ Stud. 2005, 14 (Suppl 2): 73-76.
13.
Wicherek L, Dutsch-Wicherek M, Mak P, Klimek M: The role of RCAS1 and oxytocinase in immune tolerance during pregnancy. Fetal Diagn Ther. 2005, 20: 420-425. 10.1159/000086824.CrossRefPubMed
14.
Theocharis SE, Margeli AP, Klijanienko JT, Kouraklis GP: Metallothionein expression in human neoplasia. Histopathology. 2004, 45: 103-118. 10.1111/j.1365-2559.2004.01922.x.CrossRefPubMed
15.
Cherian MG, Jayasurya A, Bay BH: Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res. 2003, 533: 201-209.CrossRefPubMed
16.
Ioachin E: Immunohistochemical tumor markers in endometrial carcinoma. Eur J Gynaecol Oncol. 2005, 26: 363-371.PubMed
17.
Klimek M, Wicherek L, Galazka K, Tetlak T, Popiela TJ, Kulczycka M, Rudnicka-Sosin L, Dutsch-Wicherek M: Cycle dependent expression of endometrial metallothionein. Neuro Endocrinol Lett. 2005, 26: 663-666.PubMed
18.
19.
Gaunt A, Heard G, McKain ES, Stephenson BM: Casarean scar endometrioma. Lancet. 2004, 364: 368-10.1016/S0140-6736(04)16726-3.CrossRefPubMed
20.
Sammour RN, Leibovitz Z, Shapiro I, Degani S, Levitan Z, Aharoni A, Tal J, Lurie M, Ohel G: Decidualization of ovarian endometriosis during pregnancy mimicking malignancy. J Ultrasound Med. 2005, 24: 1289-1294.PubMed
21.
Chao KH, Wu MY, Yang JH, Chen SU, Yang YS, Ho HN: Expression of the interleukin-2 receptor alfa (CD25) is selectively decreased on decidual CD4+ and CD8+ T lymphocytes in normal pregnancies. Mol Hum Reprod. 2002, 8: 667-673. 10.1093/molehr/8.7.667.CrossRefPubMed
22.
Maeda N, Izumiya C, Kusum T, Masumoto T, Yamashita C, Yamamoto Y, Oguri H, Fukaya T: Killer inhibitory receptor CD158a overexpression among NK cells in women with endometriosis is undiminished by laparoscopic surgery and gonadotropin releasing hormone agonist treatment. Am J Reprod Immunol. 2004, 51: 364-372. 10.1111/j.1600-0897.2004.00170.x.CrossRefPubMed
23.
Wu MH, Shoji Y, Wu MC, Chuang PC, Lin CC, Huang MF, Tsai SJ: Suppression of matrix metalloproteinase-9 by prostaglandin E(2) in peritoneal macrophage is associated with severity of endometriosis. Am J Pathol. 2005, 167: 1061-1069.PubMedCentralCrossRefPubMed
24.
Vernet-Tomas Mdel M, Perez-Ares CT, Verdu N, Molinero JL, Fernandez-Figueras MT, Carreras R: The endometria of patients with endometriosis show higher expression of class I human leukocyte antigen than the endometria of healthy women. Fertil Steril. 2006, 85: 78-83. 10.1016/j.fertnstert.2005.06.057.CrossRefPubMed
25.
Yang JH, Chen MJ, Chen HF, Lee TH, Ho HN, Yang YS: Decreased expression of killer cell inhibitory receptors on natural killer cells in eutopic endometrium in women with adenomyosis. Hum Reprod. 2004, 19: 1974-1978. 10.1093/humrep/deh372.CrossRefPubMed
26.
Zhang C, Maeda N, Izumiya C, Yamamoto Y, Kusume T, Oguri H, Yamashita C, Nishimori Y, Hayashi K, Luo J, Fukaya T: Killer immunoglobulin-like receptor and human leukocyte antigen expression as immunodiagnostic parameters for pelvic endometriosis. Am J Reprod Immunol. 2006, 55: 106-114. 10.1111/j.1600-0897.2005.00332.x.CrossRefPubMed
27.
Lebovic DI, Mueller MD, Taylor RN: Immunobiology of endometriosis. Fertil Steril. 2001, 75: 1-10. 10.1016/S0015-0282(00)01630-7.CrossRefPubMed
28.
Akoum A, Lemay A, Maheux R: Estradiol and interleukin-1beta exert a synergistic stimulatory effect on the expression of the chemokine regulated upon activation, normal T cell expressed, and secreted in endometriotic cells. J Clin Endocrinol Metab. 2002, 87: 5785-5792. 10.1210/jc.2002-020106.CrossRefPubMed
29.
Braun DP, Ding J, Shen J, Rana N, Fernandez BB, Dmowski WP: Relationship between apoptosis and the number of macrophages in eutopic endometrium from women with and without endometriosis. Fertil Steril. 2002, 78: 830-835. 10.1016/S0015-0282(02)03334-4.CrossRefPubMed
30.
Wicherek L, Galazka K, Dutsch-Wicherek M, Migdal M, Tetlak T, Klimek M: The presence of RCAS1 positive macrophages in ovarian endometriosis. Eur J Obstet Gynecol Reprod Biol. 2005, 123 (Suppl 1): S46-
31.
Dutsch-Wicherek M, Tomaszewska R, Strek P, Wicherek L, Skladzien J: The analysis of RCAS1 and DFF-45 expression in nasal polyps with respect to immune cells infiltration. BMC Immunol. 2006, 7: 4-10.1186/1471-2172-7-4.PubMedCentralCrossRefPubMed
32.
Enjoji M, Kotoh K, Nakashima M, Yoshimoto T, Miyagi Y, Kohjima M, Nakamuta M: RCAS1-expressing macrophages in inflammatory liver diseases. Liver Int. 2006, 26: 358-367. 10.1111/j.1478-3231.2005.01223.x.CrossRef
33.
Kale S, Shuster M, Shangold J: Endometrioma in cesarean scar: case report and review of literature. Am J Obstet Gynecol. 1971, 111: 596-597.PubMed
34.
Honore GM: Extrapelvic endometriosis. Clin Obstet Gynecol. 1999, 42: 699-711. 10.1097/00003081-199909000-00021.CrossRefPubMed
35.
Patterson GK, Winburn GB: Abdominal wall endometriomas: report of 8 cases. Am Surg. 1999, 65: 36-39.PubMed
36.
Rukavina D, Podack ER: Abundant perforin expression at the maternal-fetal interface: guarding the semiallogeneic transplant?. Immunol Today. 2000, 21: 160-163. 10.1016/S0167-5699(00)01603-0.CrossRefPubMed
37.
Szekeres-Bartho J, Varga B, Pacsa AS: Immunologic factors contributing to the initiation of labor-lymphocytes reactivity in term labor and threatened preterm delivery. Am J Obstet Gynecol. 1986, 155: 108-112.CrossRefPubMed
38.
Levadoux-Martin M, Hesketh JE, Beattie JH, Wallace HM: Influence of metallothionein-1 localization on its function. Biochem J. 2001, 355: 473-479. 10.1042/0264-6021:3550473.PubMedCentralCrossRefPubMed
39.
Tsangaris GT, Tzortzatou-Stathopoulou F: Metallothionein expression prevents apoptosis: a study with antisense phosphorothioate oligodeoxynucleotides in a human T cell line. Anticancer Res. 1998, 18: 2423-2433.PubMed
40.
Mocchegiani E, Muzzioli M, Giacconi R, Cipriano C, Gasparini N, Franceschi C, Gaetti R, Cavalieri E, Suzuki H: Metallothioneins/PARP-1/IL-6 interplay on natural killer cell activity in elderly: parallelism with nonagenarians and old infected humans. Effect of zinc supply. Mech Ageing Dev. 2003, 124: 459-468. 10.1016/S0047-6374(03)00023-X.CrossRefPubMed
41.
Fan LZ, Cherian MG: Potential role of p53 on metallothionein induction in human epithelial breast cancer cells. Br J Cancer. 2002, 87: 1019-1026. 10.1038/sj.bjc.6600549.PubMedCentralCrossRefPubMed
42.
Nishida M, Nasu K, Ueda T, Fukuda J, Takai N, Miyakawa I: Endometriotic cells are resistant to interferon-gamma-induced cell growth inhibition and apoptosis: a possible mechanism involved in the pathogenesis of endometriosis. Mol Hum Reprod. 2005, 11: 29-34. 10.1093/molehr/gah133.CrossRefPubMed
43.
Goumenou AG, Matalliotakis IM, Tzardi M, Fragouli YG, Mahutte NG, Arici A: Apoptosis and differential expression of apoptosis-related proteins in endometriotic glandular and stromal cells. J Soc Gynecol Investig. 2004, 11: 318-322. 10.1016/j.jsgi.2004.02.005.CrossRefPubMed
44.
Dmowski WP, Ding J, Shen J, Rana N, Fernandez BB, Braun DP: Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis. Hum Reprod. 2001, 16: 1802-1808. 10.1093/humrep/16.9.1802.CrossRefPubMed
Metadata
Title
Comparison of RCAS1 and metallothionein expression and the presence and activity of immune cells in human ovarian and abdominal wall endometriomas
Authors
Lukasz Wicherek
Magdalena Dutsch-Wicherek
Krystyna Galazka
Tomasz Banas
Tadeusz Popiela
Agata Lazar
Beata Kleinrok-Podsiadlo
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Reproductive Biology and Endocrinology / Issue 1/2006
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/1477-7827-4-41

Other articles of this Issue 1/2006

Reproductive Biology and Endocrinology 1/2006 Go to the issue

Review

Three-dimensional ultrasound assessment of endometrial receptivity: a review

Research

Effects of in vitro fertilization and embryo culture on TRP53 and Bax expression in B6 mouse embryos

Research

Co-activator p120 is increased by gonadotropins in the rat ovary and enhances progesterone receptor activity

Research

Identification, cloning and functional characterization of novel sperm associated antigen 11 (SPAG11) isoforms in the rat

Research

Studies of the role of steroid hormone in the regulation of oocyte maturation in cattle

Editorial

Novel aspects in the regulation of follicular development and ovulation rate: forum introduction